Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
dry aqueous extract of paullinia cupana seed
CINAINU
-
ebola vaccine (ad26.zebov-gp [recombinant])
ZABDENO
J07 -
ebola vaccine (mva-bn-filo [recombinant])
MVABEA
J07BX -
efalizumab
RAPTIVA
L04AA21 -
efungumab
MYCOGRAB
J02 -
elivaldogene autotemcel
SKYSONA
N07 -
emapalumab
GAMIFANT
L04AA39 -
enclomifene
ENCYZIX
G03X -
entolimod
ENTOLIMOD TMC
L03A -
epoetin delta
DYNEPO
B03XA -
eprodisate disodium
KIACTA
-
eptotermin alfa
OSIGRAFT
M05BC02 -
etarfolatide
FOLCEPRI
V09 -
faldaprevir
FALDAPREVIR BOEHRINGER INGELHEIM
J05AE -
fidanacogene elaparvovec
BEQVEZ (PREVIOUSLY DURVEQTIX)
-
fomivirsen
VITRAVENE
S01AD08 -
formoterol (fumarate)
ZENHALE
R03AK07 -
fosamprenavir
TELZIR
J05AE07 -
garenoxacin mesylate
GARENOXACIN MESYLATE
-
gbp510
SKYCOVION
J07BX03 -
govorestat
NUGALVIQ
A16AX24 -
gusperimus
SPANIDIN
-
haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine
PROCOMVAX
J07CA -
hepatitis b surface antigens recombinant (s, pre-s1, pre-s2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (c127i) cells]
HEPACARE
J07BC
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.